S A Wrighton - JoVE Visualize

Showing results (31-40 of 116) with videos related to

Pageof 12

Sort By:

Biochemical Pharmacology|February 1, 1990

Distribution of cytochromes P-450, cytochrome b5, and NADPH-cytochrome P-450 reductase in an entire human liverP B Watkins, S A Murray, P E Thomas, et al.

Biochemical Pharmacology|August 8, 1995

In vitro-in vivo correlations of human (S)-nicotine metabolismC E Berkman, S B Park, S A Wrighton, et al.

Archives of Biochemistry and Biophysics|September 1, 1992

Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic systemM A Correia, S H Davoll, S A Wrighton, et al.

Biochemical Pharmacology|July 5, 1994

Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamilyJ C Gorski, D R Jones, S A Wrighton, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1994

In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3AB J Ring, C J Parli, M C George, et al.

The Journal of Biological Chemistry|February 10, 1984

Induction of cytochrome P-450 by glucocorticoids in rat liver. I. Evidence that glucocorticoids and pregnenolone 16 alpha-carbonitrile regulate de novo synthesis of a common form of cytochrome P-450 in cultures of adult rat hepatocytes and in the liver in vivoE G Schuetz, S A Wrighton, J L Barwick, et al.

Journal of Toxicology and Environmental Health|January 1, 1986

Characterization of a unique aldo-keto reductase responsible for the reduction of chlordecone in the liver of the gerbil and manD T Molowa, S A Wrighton, R V Blanke, et al.

The Pharmacogenomics Journal|April 14, 2010

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugsD Wang, Y Guo, S A Wrighton, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1997

Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazoneJ C Gorski, D R Jones, S A Wrighton, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 20, 2000

In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicinM B Fisher, K Campanale, B L Ackermann, et al.

Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:

Pageof 12

Biochemical Pharmacology|February 1, 1990

Distribution of cytochromes P-450, cytochrome b5, and NADPH-cytochrome P-450 reductase in an entire human liverP B Watkins, S A Murray, P E Thomas, et al.

Biochemical Pharmacology|August 8, 1995

In vitro-in vivo correlations of human (S)-nicotine metabolismC E Berkman, S B Park, S A Wrighton, et al.

Archives of Biochemistry and Biophysics|September 1, 1992

Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic systemM A Correia, S H Davoll, S A Wrighton, et al.

Biochemical Pharmacology|July 5, 1994

Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamilyJ C Gorski, D R Jones, S A Wrighton, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1994

In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3AB J Ring, C J Parli, M C George, et al.

The Journal of Biological Chemistry|February 10, 1984

Induction of cytochrome P-450 by glucocorticoids in rat liver. I. Evidence that glucocorticoids and pregnenolone 16 alpha-carbonitrile regulate de novo synthesis of a common form of cytochrome P-450 in cultures of adult rat hepatocytes and in the liver in vivoE G Schuetz, S A Wrighton, J L Barwick, et al.

Journal of Toxicology and Environmental Health|January 1, 1986

Characterization of a unique aldo-keto reductase responsible for the reduction of chlordecone in the liver of the gerbil and manD T Molowa, S A Wrighton, R V Blanke, et al.

The Pharmacogenomics Journal|April 14, 2010

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugsD Wang, Y Guo, S A Wrighton, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1997

Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazoneJ C Gorski, D R Jones, S A Wrighton, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 20, 2000

In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicinM B Fisher, K Campanale, B L Ackermann, et al.

Pageof 12